Assenagon Asset Management

Assenagon Asset Management’s Atara Biotherapeutics ATRA Stock Holding History

Assenagon Asset Management’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-24,040	Closed	-$1.97M	–	1405
2022 Q4	$1.97M	Hold	24,040	–	–	0.01%	818
2022 Q3	$2.27M	Sell	24,040 -211	-0.9%	-$23.7K	0.01%	667
2022 Q2	$4.72M	Sell	24,251 -4,936	-17%	-$806K	0.02%	562
2022 Q1	$6.78M	Sell	29,187 -48,766	-63%	-$15.5M	0.02%	464
2021 Q4	$30.7M	Buy	77,953 +17,564	+29%	+$7.39M	0.09%	159
2021 Q3	$27M	Buy	60,389 +512	+0.9%	+$183K	0.09%	178
2021 Q2	$23.3M	Buy	+59,877	New	+$21.4M	0.08%	206
2020 Q3	–	Sell	-30,948	Closed	-$11.3M	–	1117
2020 Q2	$11.3M	Buy	+30,948	New	+$7.82M	0.07%	171
2020 Q1	–	Sell	-16,849	Closed	-$6.94M	–	790
2019 Q4	$6.94M	Buy	+16,849	New	+$5.81M	0.04%	209
2018 Q4	–	Sell	-16,621	Closed	-$17.2M	–	995
2018 Q3	$17.2M	Buy	16,621 +7,114	+75%	+$6.96M	0.17%	121
2018 Q2	$8.73M	Buy	9,507 +4,018	+73%	+$4.32M	0.1%	190
2018 Q1	$5.35M	Buy	+5,489	New	+$5M	0.07%	221

Other funds holding ATRA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return